Our findings revealed a robust enhancement of myeloid cells in the tumor and spleen, along with the development of tumor‐resident CD8+ TIL and circulating long‐lived effector T cells that were equipped with heightened pro‐inflammatory cytokine production. This evidence concerns the gene CD8A and neoplasm.